GrowingStockReport.com

Merck & Co. Inc. (NYSE:MRK) and Johnson & Johnson (NYSE:JNJ) Added to Growing Stock Report's NYSE Decliners Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 12/12/2013 -- -- Growing Stock Report expands its NYSE Decliners Weekly Watch List adding Merck & Co. Inc. (NYSE:MRK) and Johnson & Johnson (NYSE:JNJ).

Merck & Co. Inc. (NYSE:MRK) a company that provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide is currently down (-1.51%) on 5,313,515 shares traded as Merck Advances Development Program for Investigational Alzheimer’s Disease Therapy, MK-8931. Merck & Co. Inc. (NYSE:MRK) is currently down (-4.74%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NYSE Decliners Watch List.

Click Here to find out what other Investors are saying about Merck & Co. Inc. (NYSE:MRK)

Johnson & Johnson (NYSE:JNJ) a company that together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide is currently down (-2.05%) on 6,187,842 shares traded after TheStreet Ratings rated Johnson & Johnson as a buy. Johnson & Johnson (NYSE:JNJ) is currently down (-5.13%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NYSE Decliners Watch List.

Click Here to find out what other Investors are saying about Johnson & Johnson (NYSE:JNJ)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com